GlassScriptPhysician profile
Khalid H Ashai
NPI 1912986035
$7,787.89
in general payments reported to CMS, 2019-2025
38 companies · $1,428 in 2025
The $1,428 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $599 · 2021: $1,303 · 2022: $827 · 2023: $1,265 · 2024: $1,970 · 2025: $1,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,553 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,552.67 |
| Education | $110.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $801.57 | 2019-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $539.74 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $518.03 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $512.58 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $486.64 | 2019-2024 | Xarelto, Uptravi |
| Novartis Pharmaceuticals Corporation | $449.63 | 2020-2025 | |
| Abbott Laboratories | $448.65 | 2020-2025 | Diamondback Peripheral, Jot Dx, Amplatzer |
| Boston Scientific Corporation | $395.57 | 2019-2025 | Bodyguardian, Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $380.32 | 2022-2025 | |
| Novo Nordisk INC | $316.32 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $313.32 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $302.61 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Medtronic, INC. | $301.47 | 2021-2024 | Micra, Venaseal, Hawkone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $249.96 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $208.94 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $190.81 | 2023-2025 | Eliquis, Camzyos |
| Lexicon Pharmaceuticals, INC. | $183.15 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $155.66 | 2020-2025 | Nexletol |
| Cardiovascular Systems INC. | $109.92 | 2019-2023 | Diamondback Peripheral |
| Bard Peripheral Vascular, INC. | $94.75 | 2020 | |
| Baxter Healthcare | $94.30 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Shockwave Medical, INC | $83.70 | 2021 | |
| Medtronic Vascular, INC. | $81.81 | 2019-2020 | |
| Kiniksa Pharmaceuticals, LTD. | $80.79 | 2022-2023 | Arcalyst |
| Kiniksa Pharmaceuticals International, Plc | $73.33 | 2024 | Arcalyst |
| Lilly USA, LLC | $62.43 | 2020-2025 | Zepbound, Mounjaro |
| Atricure, INC. | $59.96 | 2024 | |
| Bridgebio Pharma, INC. | $40.94 | 2025 | Attruby |
| Arbor Pharmaceuticals, INC. | $40.46 | 2019-2021 | |
| Philips North America LLC | $37.04 | 2022-2023 | |
| Abiomed | $30.23 | 2024 | Impella |
| Alnylam Pharmaceuticals INC. | $24.94 | 2025 | Amvuttra |
| Celgene Corporation | $23.70 | 2025 | Camzyos |
| Scpharmaceuticals INC. | $23.25 | 2025 | |
| Glaxosmithkline, LLC. | $21.32 | 2025 | Arexvy, Shingrix |
| Cook Medical LLC | $19.31 | 2021 | |
| W. L. Gore & Associates, INC. | $16.74 | 2021 | |
| Sandoz INC. | $14.00 | 2023 | Treprostinil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Ashai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.